{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:04:25Z","timestamp":1791309865881,"version":"4.3.1"},"reference-count":32,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.antiviral.2013.11.015","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T02:16:24Z","timestamp":1386209784000},"page":"29-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Amino acid similarities and divergences in the small surface proteins of genotype C hepatitis B viruses between nucleos(t)ide analogue-na\u00efve and lamivudine-treated patients with chronic hepatitis B"],"prefix":"10.1016","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7314-8538","authenticated-orcid":false,"given":"Hai","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhui","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2013.11.015_b0005","first-page":"2159","article-title":"Guideline on prevention and treatment of chronic hepatitis B in China","volume":"120","author":"Chinese Medical Association","year":"2007","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.antiviral.2013.11.015_b0010","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrgastro.2009.107","article-title":"Hepatitis B virus variants","volume":"6","author":"Chotiyaputta","year":"2009","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.antiviral.2013.11.015_b0015","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1002\/jmv.20605","article-title":"Hepatitis B virus genetic diversity","volume":"78","author":"Echevarria","year":"2006","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.11.015_b0020","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00535-007-2085-1","article-title":"Mutations in preS genes of genotype C hepatitis B virus in patients with chronic hepatitis B and hepatocellular carcinoma","volume":"42","author":"Gao","year":"2007","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.antiviral.2013.11.015_b0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/rmv.705","article-title":"Countering hepatitis B virus infection using RNAi: how far are we from the clinic?","volume":"21","author":"Ivacik","year":"2011","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.11.015_b0030","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1128\/JVI.02701-12","article-title":"Impaired virion secretion by hepatitis B virus immune escape mutants and its rescue by wild-type envelope proteins or a second-site mutation","volume":"87","author":"Kwei","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.11.015_b0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jhep.2011.06.028","article-title":"Nucleotide change of codon 182 in the surface gene of hepatitis B virus genotype C leading to truncated surface protein is associated with progression of liver diseases","volume":"56","author":"Lee","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2013.11.015_b0040","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jmv.23182","article-title":"Discrepancy of potential antiviral resistance mutation profiles within the HBV reverse transcriptase between nucleos(t)ide analogue-untreated and -treated patients with chronic hepatitis B in a hospital in China","volume":"84","author":"Li","year":"2012","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.11.015_b0045","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.antiviral.2009.12.006","article-title":"Characterization of potential antiviral resistance mutations in hepatitis B virus reverse transcriptase sequences in treatment-na\u00efve Chinese patients","volume":"85","author":"Liu","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2013.11.015_b0050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3851\/IMP1499","article-title":"Molecular genesis of drug-resistant and vaccine-escape HBV mutants","volume":"15","author":"Locarnini","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2013.11.015_b0055","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hep.21698","article-title":"Antiviral drug-resistant HBV: standardization of nomenclature and assays and recommendations for management","volume":"46","author":"Lok","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2013.11.015_b0060","first-page":"3","article-title":"Management of hepatitis B in China","volume":"122","author":"Lu","year":"2009","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.antiviral.2013.11.015_b0065","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2893.2010.01282.x","article-title":"Diversity of hepatitis B virus infecting Malaysian candidate blood donors is driven by viral and host factors","volume":"18","author":"Meldal","year":"2011","journal-title":"J. Viral Hepatitis"},{"key":"10.1016\/j.antiviral.2013.11.015_b0070","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.antiviral.2012.09.014","article-title":"Genotype-specific mutations in the polymerase gene of hepatitis B virus potentially associated with resistance to oral antiviral therapy","volume":"96","author":"Mirandola","year":"2012","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2013.11.015_b0075","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/367908","article-title":"Effects of HBV genetic variability on RNAi strategies","author":"Panjaworayan","year":"2011","journal-title":"Hepat. Res. Treat."},{"key":"10.1016\/j.antiviral.2013.11.015_b0080","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1177\/135965350901400504","article-title":"Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients","volume":"14","author":"Pollicino","year":"2009","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2013.11.015_b0085","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jmv.21104","article-title":"Naturally occurring MHR variants in Turkish patients infected with hepatitis B virus","volume":"80","author":"Sayiner","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.11.015_b0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/v1020185","article-title":"HBV life cycle: entry and morphogenesis","volume":"1","author":"Schadler","year":"2009","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2013.11.015_b0095","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/JVI.02500-12","article-title":"Role of transmembrane domains of hepatitis B virus small surface proteins insubviral-particle biogenesis","volume":"87","author":"Siegler","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.11.015_b0100","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/135965350501000612","article-title":"Selection of hepatitis B virus polymerase mutations in HIV-coinfected patients treated with tenofovir","volume":"10","author":"Sheldon","year":"2005","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2013.11.015_b0105","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/jac\/dkn014","article-title":"Hepatitis B virus escape mutants induced by antiviral therapy","volume":"61","author":"Sheldon","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2013.11.015_b0110","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/135965350801300313","article-title":"Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant","volume":"13","author":"Sloan","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2013.11.015_b0115","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2008.07.038","article-title":"The profile of mutational clusters associated with lamivudine resistance can be constrained by HBV genotypes","volume":"50","author":"Svicher","year":"2009","journal-title":"J. Hepatol."},{"key":"10.1016\/j.antiviral.2013.11.015_b0120","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3851\/IMP1556","article-title":"Potential threat of drug-resistant and vaccine-escape HBV mutants to public health","volume":"15","author":"Teo","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2013.11.015_b0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/viro.2001.1246","article-title":"Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy","volume":"293","author":"Torresi","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2013.11.015_b0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/135965350801300314","article-title":"Hepatitis B antiviral resistance and vaccine escape: two sides of the same coin","volume":"13","author":"Torresi","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2013.11.015_b0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jmv.10205","article-title":"Prevalence and profile of mutations associated with lamivudine therapy in Indian patients with chronic hepatitis B in the surface and polymerase genes of hepatitis B virus","volume":"68","author":"Wakil","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.antiviral.2013.11.015_b0140","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcv.2004.10.008","article-title":"Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact","volume":"32","author":"Weber","year":"2005","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2013.11.015_b0145","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2002.34740","article-title":"Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60weeks","volume":"36","author":"Yang","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2013.11.015_b0150","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3851\/IMP1677","article-title":"Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside\/nucleotide analogue treatment among Chinese chronic hepatitis B patients","volume":"15","author":"Yang","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2013.11.015_b0155","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3851\/IMP1552","article-title":"Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide\/nucleoside analogue therapy","volume":"15","author":"Yeh","year":"2010","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2013.11.015_b0160","first-page":"260","article-title":"A novel reverse transcriptase mutation in genotype C hepatitis B virus associated with rtM204I\/V drug resistant mutation","volume":"2","author":"Zhao","year":"2012","journal-title":"Chin. J. Viral. Dis."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213003574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213003574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T14:26:35Z","timestamp":1688826395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213003574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":32,"alternative-id":["S0166354213003574"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.11.015","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amino acid similarities and divergences in the small surface proteins of genotype C hepatitis B viruses between nucleos(t)ide analogue-na\u00efve and lamivudine-treated patients with chronic hepatitis B","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.11.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}